H.C. Wainwright Maintains Chimerix(CMRX.US) With Buy Rating, Maintains Target Price $11

Moomoo News4minutes ago · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target

Benzinga7minutes ago

Chimerix Analyst Ratings

Benzinga9minutes ago · Ratings

Edward White's Buy Rating on Chimerix Driven by Promising Clinical Data and Strategic NDA Plans

TipRanks21minutes ago · Ratings

CervoMed CRVO Phase 2b Fails; Chimerix SNDA Application

BioPharmCatalyst16:10 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga16:05 ET